Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

VBI Vaccines Announced Interim Data From The Phase 1 Study Of Its Multivalent Pan-coronavirus Vaccine Candidate, VBI-2901, Based On Interim Data, Peak Responses Were Achieved With Only A Single 10µg Dose Of VBI-2901

Author: Benzinga Newsdesk | September 27, 2023 07:34am

Posted In: VBIV

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist